Sodexo S.A. | Large-cap | Industrials

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 23.8B
Gross Profit 2.8B 11.95%
Operating Income 1.0B 4.31%
Net Income 177.0M 0.74%
EPS (Diluted) €1.13

Balance Sheet Metrics

Total Assets 15.0B
Total Liabilities 11.2B
Shareholders Equity 3.8B
Debt to Equity 2.96

Cash Flow Metrics

Operating Cash Flow 853.0M
Free Cash Flow 962.0M

Revenue & Profitability Trend

Sodexo S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue23.8B22.6B20.3B17.4B19.3B
Cost of Goods Sold21.0B19.9B17.8B15.0B16.8B
Gross Profit2.8B2.7B2.5B2.4B2.5B
Operating Expenses1.8B1.8B1.7B1.9B1.9B
Operating Income1.0B890.0M757.0M540.0M508.0M
Pre-tax Income996.0M749.0M726.0M237.0M-221.0M
Income Tax249.0M181.0M206.0M101.0M98.0M
Net Income177.0M802.0M701.0M137.0M-319.0M
EPS (Diluted)€1.13€5.38€4.69€0.94-€2.16

Income Statement Trend

Sodexo S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets6.4B11.4B10.1B9.6B7.6B
Non-Current Assets8.6B9.4B10.8B9.4B9.7B
Total Assets15.0B20.8B20.9B19.0B17.4B
Liabilities
Current Liabilities5.9B9.8B9.3B8.9B7.7B
Non-Current Liabilities5.3B6.4B7.2B7.0B6.8B
Total Liabilities11.2B16.2B16.5B15.8B14.6B
Equity
Total Shareholders Equity3.8B4.6B4.4B3.2B2.8B

Balance Sheet Composition

Sodexo S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income1.1B847.0M812.0M339.0M65.0M
Operating Cash Flow853.0M620.0M331.0M125.0M688.0M
Investing Activities
Capital Expenditures-323.0M-305.0M-249.0M-224.0M-381.0M
Investing Cash Flow-1.1B-447.0M-312.0M-297.0M-398.0M
Financing Activities
Dividends Paid-1.4B-352.0M-294.0M--425.0M
Financing Cash Flow-1.2B-454.0M-910.0M1.0B468.0M
Free Cash Flow962.0M995.0M769.0M686.0M234.0M

Cash Flow Trend

Sodexo S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 11.39
Forward P/E 8.22
Price to Book 1.90
Price to Sales 0.31
PEG Ratio 8.22

Profitability Ratios

Profit Margin 2.80%
Operating Margin 5.00%
Return on Equity 16.24%
Return on Assets 4.27%

Financial Health

Current Ratio 1.08
Debt to Equity 139.45
Beta 0.48

Per Share Data

EPS (TTM) €4.57
Book Value per Share €27.33
Revenue per Share €165.30

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sw7.6B11.391.9016.24%2.80%139.45
Verallia S.A 3.3B14.083.3323.56%6.82%213.62
Groupe Guillin 551.2M8.920.849.83%6.86%14.02
TFF 481.3M12.070.978.11%8.61%73.32
Gascogne S.A 99.2M8.210.43-0.31%-0.16%127.87
Augros Cosmetic 10.0M15.3516.28-139.28%-17.68%696.58

Financial data is updated regularly. All figures are in the company's reporting currency.